Showing results (171-180 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|June 28, 2017
Oncology drugs for orphan indications: how are HTA processes evolving for this specific drug category?Elizabeth M Adkins, Lindsay Nicholson, David Floyd, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 20, 2023
Biosimilars Adoption: Recognizing and Removing the RoadBlocksSarfaraz K Niazi
Clinicoeconomics and Outcomes Research : CEOR|April 23, 2021
Cost Analysis in Helicobacter pylori Eradication Therapy Based on a Database of Health Insurance Claims in JapanKengo Tokunaga, Chihiro Suzuki, Miyuki Hasegawa, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 13, 2012
Cost comparison of second-line treatment options for late stage non-small-cell lung cancer: cost analysis for ItalyBjoern Schwander, Simona Ravera, Giovanni Giuliani, et al.
Clinicoeconomics and Outcomes Research : CEOR|September 15, 2012
Cost of rheumatoid arthritis in a selected population from Argentina in the prebiologic therapy eraErika Catay, Cecilia Castel Del Cid, Lorena Narváez, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 9, 2020
Malnutrition Prevalence and Burden on Healthcare Resource Use Among Spanish Community-Living Older Adults: Results of a Longitudinal AnalysisBeatriz Rodríguez-Sánchez, Suela Sulo, José Antonio Carnicero, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 9, 2020
Switch Rates and Total Cost of Care Associated with Apremilast and Biologic Therapies in Biologic-Naive Patients with Plaque PsoriasisDavid L Kaplan, Brian L Ung, Corey Pelletier, et al.
Clinicoeconomics and Outcomes Research : CEOR|August 22, 2020
Cost of Hemodialysis Treatment and Associated Factors Among End-Stage Renal Disease Patients at the Tertiary Hospitals of Addis Ababa City and Amhara Region, EthiopiaDaniel Asrat Kassa, Solomon Mekonnen, Adane Kebede, et al.
Pageof 102